Scenario description
Assume Onsemi completes its amended all-cash acquisition of Synaptics at $123 per share by the resolution date, with Synaptics shareholders receiving the cash consideration on materially the revised terms reported by MarketBrief. The transaction value is about $5.7 billion, and Onsemi funds the purchase with available cash and committed Morgan Stanley debt financing; exact debt draw, final cash balances, integration timing, and realized synergy amounts remain unspecified beyond Onsemi’s stated expectation of more than $200 million in annual run-rate synergies.